These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8271057)

  • 1. Carbon dioxide reactivity by consecutive technetium-99m-HMPAO SPECT in patients with a chronically obstructed major cerebral artery.
    Oku N; Matsumoto M; Hashikawa K; Moriwaki H; Okazaki Y; Seike Y; Handa N; Uehara T; Kamada T; Nishimura T
    J Nucl Med; 1994 Jan; 35(1):32-40. PubMed ID: 8271057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pre and post operative evaluation of the perfusion reserve by acetazolamide 99mTc-HMPAO SPECT in patients with chronic occlusive cerebral arteries: a comparative study with PET].
    Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    Kaku Igaku; 1994 Sep; 31(9):1039-50. PubMed ID: 7967187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT.
    Burt RW; Witt RM; Cikrit DF; Reddy RV
    Radiology; 1992 Feb; 182(2):461-6. PubMed ID: 1732965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease.
    Knop J; Thie A; Fuchs C; Siepmann G; Zeumer H
    Stroke; 1992 Dec; 23(12):1733-42. PubMed ID: 1448823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofixation and hyperfixation of 99mTc-hexamethyl propyleneamine oxime in subacute cerebral infarction.
    Ogasawara K; Ogawa A; Koshu K; Konno H; Suzuki M; Yoshimoto T
    J Nucl Med; 2000 May; 41(5):795-9. PubMed ID: 10809194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of postural cerebral hypoperfusion with technetium-99m-HMPAO brain SPECT in patients with cerebrovascular disease.
    Hayashida K; Hirose Y; Kaminaga T; Ishida Y; Imakita S; Takamiya M; Yokota I; Nishimura T
    J Nucl Med; 1993 Nov; 34(11):1931-5. PubMed ID: 8229237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of change ratio map in 99mTc-HMPAO SPECT with acetazolamide enhancement].
    Yamamoto N
    Kaku Igaku; 1996 Apr; 33(4):399-408. PubMed ID: 8683879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing collateral cerebral perfusion with technetium-99m-HMPAO SPECT during temporary internal carotid artery occlusion.
    Palestro CJ; Sen C; Muzinic M; Afriyie M; Goldsmith SJ
    J Nucl Med; 1993 Aug; 34(8):1235-8. PubMed ID: 8326377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SPECT evaluation of cerebral perfusion reserve in patients with occlusive cerebrovascular diseases: evaluation with acetazolamide test and crossed cerebellar diaschisis].
    Sugawara Y
    Kaku Igaku; 1995 Mar; 32(3):287-99. PubMed ID: 7739159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebral single-photon emission-computed tomography. A semiquantitative analysis of vascular areas in patients with cerebrovascular pathology].
    Torres G; Martínez-Duncker C; Pujol J; Estorch M; Berná L; Martí-Vilalta JL; Carrió I
    Med Clin (Barc); 1992 Feb; 98(7):241-4. PubMed ID: 1560698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease.
    Heiss WD; Herholz K; Podreka I; Neubauer I; Pietrzyk U
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):687-97. PubMed ID: 2384541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral perfusion reserve SPECT imaging before and during acetazolamide test using consecutive 99mTc-HMPAO SPECT].
    Terada H; Gomi T; Furukawa T; Murakami S; Sato S; Nagamoto M; Sekiguchi R; Kuwajima A; Hiramatsu Y; Sakai T
    Kaku Igaku; 1991 May; 28(5):509-15. PubMed ID: 1886285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Raise up 99mTc-HMPAO brain SPECT for detecting the changes in cerebral perfusion pressure].
    Hayashida K; Nishimura T; Uehara T; Kaminaga T; Hirose Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):1036-8. PubMed ID: 1508649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Brain 99mTc-Ethyl Cysteinate Dimer SPECT Imaging and Analysis to Detect Misery Perfusion on 15O PET Imaging in Patients With Chronic Occlusive Disease of Unilateral Major Cerebral Artery.
    Matsumoto Y; Oikawa K; Nomura JI; Kojima D; Oshida S; Kobayashi M; Terasaki K; Kubo Y; Ogasawara K
    Clin Nucl Med; 2017 Jul; 42(7):499-505. PubMed ID: 28481786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of subacute stroke with high uptake of 99mTc-HMPAO in the reperfused infarct corresponding to low perfusion area].
    Sugawara Y; Tanada S; Murase K; Inoue T; Miki H; Okumura A; Hamamoto K; Ueda T; Ohta S; Sakaki S
    Kaku Igaku; 1994 Jun; 31(6):603-7. PubMed ID: 8072234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of perfusion CT and 99m Tc-HMPAO SPECT measurement to assess cerebrovascular reserve capacity in patients with internal carotid artery occlusion.
    Eicker SO; Turowski B; Heiroth HJ; Steiger HJ; Hänggi D
    Eur J Med Res; 2011 Nov; 16(11):484-90. PubMed ID: 22027641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO.
    Matsuda H; Higashi S; Kinuya K; Tsuji S; Nozaki J; Sumiya H; Hisada K; Yamashita J
    Clin Nucl Med; 1991 Aug; 16(8):572-9. PubMed ID: 1934810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide-challenged perfusion magnetic resonance imaging for assessment of cerebrovascular reserve capacity in patients with symptomatic middle cerebral artery stenosis: comparison with technetium-99m-hexamethylpropyleneamine oxime single-photon emission computed tomography.
    Kim HJ; Kim TW; Ryu SY; Yang PS; Kwon MJ; Kim JC; Lee YS; Lee HJ; Yang JH; Kim JK; Chung YA; Oh EY; Lee SB
    Clin Imaging; 2011; 35(6):413-20. PubMed ID: 22040783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.
    Asenbaum S; Brücke T; Pirker W; Pietrzyk U; Podreka I
    J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined SPECT imaging of regional cerebral blood flow (99mTc-hexamethyl-propyleneamine oxime, HMPAO) and blood volume (99mTc-RBC) to assess regional cerebral perfusion reserve in patients with cerebrovascular disease.
    Buell U; Braun H; Ferbert A; Stirner H; Weiller C; Ringelstein EB
    Nuklearmedizin; 1988 Mar; 27(2):51-6. PubMed ID: 3259313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.